GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (NSE:BLISSGVS) » Definitions » E10

Bliss GVS Pharma (NSE:BLISSGVS) E10 : ₹9.64 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Bliss GVS Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bliss GVS Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹2.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹9.64 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Bliss GVS Pharma's average E10 Growth Rate was -5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-10), Bliss GVS Pharma's current stock price is ₹116.41. Bliss GVS Pharma's E10 for the quarter that ended in Dec. 2024 was ₹9.64. Bliss GVS Pharma's Shiller PE Ratio of today is 12.08.

During the past 13 years, the highest Shiller PE Ratio of Bliss GVS Pharma was 18.51. The lowest was 7.30. And the median was 12.07.


Bliss GVS Pharma E10 Historical Data

The historical data trend for Bliss GVS Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma E10 Chart

Bliss GVS Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 9.65

Bliss GVS Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.16 9.65 9.85 10.08 9.64

Competitive Comparison of Bliss GVS Pharma's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bliss GVS Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bliss GVS Pharma's Shiller PE Ratio falls into.


;
;

Bliss GVS Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bliss GVS Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=2.27/158.3229*158.3229
=2.270

Current CPI (Dec. 2024) = 158.3229.

Bliss GVS Pharma Quarterly Data

per share eps CPI Adj_EPS
201503 0.000 97.163 0.000
201506 1.890 99.841 2.997
201509 2.230 101.753 3.470
201512 2.150 102.901 3.308
201603 1.710 102.518 2.641
201606 2.670 105.961 3.989
201609 2.460 105.961 3.676
201612 2.020 105.196 3.040
201703 3.210 105.196 4.831
201706 2.050 107.109 3.030
201709 4.930 109.021 7.159
201712 1.740 109.404 2.518
201803 -1.390 109.786 -2.005
201806 1.760 111.317 2.503
201809 4.020 115.142 5.528
201812 2.500 115.142 3.438
201903 1.750 118.202 2.344
201906 3.280 120.880 4.296
201909 3.000 123.175 3.856
201912 2.300 126.235 2.885
202003 0.850 124.705 1.079
202006 1.540 127.000 1.920
202009 1.540 130.118 1.874
202012 2.430 130.889 2.939
202103 0.580 131.771 0.697
202106 2.290 134.084 2.704
202109 2.010 135.847 2.343
202112 -4.830 138.161 -5.535
202203 1.870 138.822 2.133
202206 2.440 142.347 2.714
202209 1.330 144.661 1.456
202212 2.640 145.763 2.867
202303 0.330 146.865 0.356
202306 1.380 150.280 1.454
202309 3.980 151.492 4.159
202312 2.600 152.924 2.692
202403 -0.880 153.035 -0.910
202406 1.930 155.789 1.961
202409 2.290 157.882 2.296
202412 2.270 158.323 2.270

Add all the adjusted EPS together and divide 10 will get our e10.


Bliss GVS Pharma  (NSE:BLISSGVS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bliss GVS Pharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=116.41/9.64
=12.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bliss GVS Pharma was 18.51. The lowest was 7.30. And the median was 12.07.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bliss GVS Pharma E10 Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Bliss GVS Pharma Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from exports.

Bliss GVS Pharma Headlines

No Headlines